Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis

6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis

US Patent 9150519 · Granted Oct 6, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2022
Non brain penetrant A2A inhibitors and methods for use in the treatment of cance2022
Thiocarbamate derivatives as A2A inhibitors, pharmaceutical composition thereof 2022
1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotat2021
2-oxo-thiazole derivatives as A2A inhibitors and compounds for use in the treatm2021
Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body2021
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2020
3-indol substituted derivatives, pharmaceutical compositions and methods for use2020
Treatment method utilizing pyrrolidine-2, 5-dione derivatives as IDO1 inhibitors2019
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt 2019
Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for 2018
Amine derivatives as potassium channel blockers2018